October 23, 2014 12:52 AM ET


Company Overview of Enanta Pharmaceuticals, Inc.

Key Executives for Enanta Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jay R. Luly Ph.D.40 RelationshipsChief Executive Officer, President and Director58
Paul J. Mellett Jr.No RelationshipsChief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance & Administration59
Nathaniel S. Gardiner J.D.No RelationshipsSenior Vice President and General Counsel --
Timothy D. Ocain Ph.D.10 RelationshipsSenior Vice President of New Product Strategy and Development--
Yat Sun Or Ph.D.No RelationshipsChief Scientific Officer and Senior Vice President of Research & Development62

Enanta Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel Jan Ellens Ph.D. 42 RelationshipsLife Sciences Partners BV66
Jay R. Luly Ph.D. 40 RelationshipsEnanta Pharmaceuticals, Inc.58
Terry C. Vance 30 RelationshipsSaints Capital58
Stephen Buckley Jr. 15 RelationshipsEnanta Pharmaceuticals, Inc.65
Ernst-Günter Afting Ph.D., M.D. 35 RelationshipsEnanta Pharmaceuticals, Inc.72
View All Board Members

Enanta Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Stephen Buckley15 Relationships3 Executives
Nominating Committee Terry C. Vance30 Relationships5 Executives
Corporate Governance Committee Terry C. Vance30 Relationships5 Executives
Supervisory Board Ph.D.Daniel Jan Ellens42 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$683.9K
Compensation as of Fiscal Year 2013
Enanta Pharmaceuticals, Inc. CEO Compensation
Industry Average


McBride Announces Job Cuts; Chris Smith to Join as Finance Director, Effective from January 7, 2015
October 21, 2014 7:34 AM ET
Colgate-Palmolive Co. Announces Executive Changes
October 16, 2014 8:23 PM ET
Hindustan Unilever Limited Appoints Kalpana Morparia as an Independent Director on the Board
October 09, 2014 12:28 PM ET
Harish Manwani to Retires as COO of Hindustan Unilever Limited on December 31, 2014
October 08, 2014 6:23 AM ET
Farmax India Limited Approves Appointment of Directors
October 01, 2014 2:21 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.